How does your organization view noncompliance investigations? Are they seen as an opportunity for learning and growth? If we are…
Read MorePediatric subjects participating in HHS-funded or FDA-regulated studies are afforded additional protections not codified in subpart A of the Federal…
Read MoreCOVID-19 presents enormous challenges to research ethics oversight. Here, we’ve begun a collection of oversight-related resources in order to best…
Read MoreI was eager to attend the session "Reviewing Exercise Science Research at Primarily SBER Institutions" (speakers: Summer B. Cook, PhD;…
Read MoreToday, PRIM&R submitted comments (PDF) to the White House Office of Science and Technology Policy (OSTP) in response to their…
Read More